APO Research
Talk to an analyst

APO RESEARCH · REPORT

Knee-high Anti-Embolism Socks

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Knee-high Anti-Embolism Socks Market Outlook and Growth Opportunities 2026

6 January 2026203 pages

Choose your research edition.

Industry ResearchKnee-high Anti-Embolism Socks Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Knee-high Anti-Embolism Socks Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Knee-high Anti-Embolism Socks Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Knee-high Anti-Embolism Socks Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Knee-high Anti-Embolism Socks Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Knee-high Anti-Embolism Socks market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Knee-high Anti-Embolism Socks is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Knee-high Anti-Embolism Socks is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Knee-high Anti-Embolism Socks is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Knee-high Anti-Embolism Socks market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Knee-high Anti-Embolism Socks market include Varitek, Medtronic(Covidien), Sigvaris, Medi, BSN Medical, Juzo, 3M, Bauerfeind AG and Thuasne Corporate, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Knee-high Anti-Embolism Socks market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Knee-high Anti-Embolism Socks and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Knee-high Anti-Embolism Socks sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Knee-high Anti-Embolism Socks market size, projected growth trends, production technologies, key applications, and end-use industries.

Knee-high Anti-Embolism Socks Segment by Company

Varitek

Medtronic(Covidien)

Sigvaris

Medi

BSN Medical

Juzo

3M

Bauerfeind AG

Thuasne Corporate

Pretty Legs Hosiery

Salzmann-Group

Paul Hartmann

Cizeta Medicali

Belsana Medical

Gloria Med

Zhende Medical Group

Maizi

TOKO

Okamoto Corporation

Knee-high Anti-Embolism Socks Segment by Type

Open Toes

Closed Toes

Knee-high Anti-Embolism Socks Segment by Application

Online Sales

Offline Sales

Knee-high Anti-Embolism Socks Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Knee-high Anti-Embolism Socks status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Knee-high Anti-Embolism Socks market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Knee-high Anti-Embolism Socks significant trends, drivers, influence factors in global and regions.

6. To analyze Knee-high Anti-Embolism Socks competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Knee-high Anti-Embolism Socks market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Knee-high Anti-Embolism Socks and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Knee-high Anti-Embolism Socks.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Knee-high Anti-Embolism Socks market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Knee-high Anti-Embolism Socks industry.

Chapter 3: Detailed analysis of Knee-high Anti-Embolism Socks manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Knee-high Anti-Embolism Socks in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Knee-high Anti-Embolism Socks in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Knee-high Anti-Embolism Socks Industry Trends Table 2. Knee-high Anti-Embolism Socks Industry Drivers Table 3. Knee-high Anti-Embolism Socks Industry Opportunities and Challenges Table 4. Knee-high Anti-Embolism Socks Industry Restraints Table 5. Global Knee-high Anti-Embolism Socks Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Knee-high Anti-Embolism Socks Revenue Share by Company (2021-2026) Table 7. Global Knee-high Anti-Embolism Socks Sales Volume by Company (k pairs) & (2021-2026) Table 8. Global Knee-high Anti-Embolism Socks Sales Volume Share by Company (2021-2026) Table 9. Global Knee-high Anti-Embolism Socks Average Price (USD/pair) of Company (2021-2026) Table 10. Global Knee-high Anti-Embolism Socks Company Ranking, (2024-2026) & (USD Million) Table 11. Global Knee-high Anti-Embolism Socks Key Company Manufacturing Base & Headquarters Table 12. Global Knee-high Anti-Embolism Socks Company, Product Type & Application Table 13. Global Knee-high Anti-Embolism Socks Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Knee-high Anti-Embolism Socks by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Open Toes Table 18. Significant Companies of Closed Toes Table 19. Global Knee-high Anti-Embolism Socks Sales Volume by Type 2021 VS 2025 VS 2032 (k pairs) Table 20. Global Knee-high Anti-Embolism Socks Sales Volume by Type (2021-2026) & (k pairs) Table 21. Global Knee-high Anti-Embolism Socks Sales Volume by Type (2027-2032) & (k pairs) Table 22. Global Knee-high Anti-Embolism Socks Sales Volume Share by Type (2021-2026) Table 23. Global Knee-high Anti-Embolism Socks Sales Volume Share by Type (2027-2032) Table 24. Global Knee-high Anti-Embolism Socks Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Knee-high Anti-Embolism Socks Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Knee-high Anti-Embolism Socks Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Knee-high Anti-Embolism Socks Sales Value Share by Type (2021-2026) Table 28. Global Knee-high Anti-Embolism Socks Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Sales Table 30. Significant Companies of Offline Sales Table 31. Global Knee-high Anti-Embolism Socks Sales Volume by Application 2021 VS 2025 VS 2032 (k pairs) Table 32. Global Knee-high Anti-Embolism Socks Sales Volume by Application (2021-2026) & (k pairs) Table 33. Global Knee-high Anti-Embolism Socks Sales Volume by Application (2027-2032) & (k pairs) Table 34. Global Knee-high Anti-Embolism Socks Sales Volume Share by Application (2021-2026) Table 35. Global Knee-high Anti-Embolism Socks Sales Volume Share by Application (2027-2032) Table 36. Global Knee-high Anti-Embolism Socks Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Knee-high Anti-Embolism Socks Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Knee-high Anti-Embolism Socks Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Knee-high Anti-Embolism Socks Sales Value Share by Application (2021-2026) Table 40. Global Knee-high Anti-Embolism Socks Sales Value Share by Application (2027-2032) Table 41. Global Knee-high Anti-Embolism Socks Sales by Region: 2021 VS 2025 VS 2032 (k pairs) Table 42. Global Knee-high Anti-Embolism Socks Sales by Region (2021-2026) & (k pairs) Table 43. Global Knee-high Anti-Embolism Socks Sales Market Share by Region (2021-2026) Table 44. Global Knee-high Anti-Embolism Socks Sales by Region (2027-2032) & (k pairs) Table 45. Global Knee-high Anti-Embolism Socks Sales Market Share by Region (2027-2032) Table 46. Global Knee-high Anti-Embolism Socks Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Knee-high Anti-Embolism Socks Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Knee-high Anti-Embolism Socks Sales Value Share by Region (2021-2026) Table 49. Global Knee-high Anti-Embolism Socks Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Knee-high Anti-Embolism Socks Sales Value Share by Region (2027-2032) Table 51. Global Knee-high Anti-Embolism Socks Market Average Price (USD/pair) by Region (2021-2026) Table 52. Global Knee-high Anti-Embolism Socks Market Average Price (USD/pair) by Region (2027-2032) Table 53. Global Knee-high Anti-Embolism Socks Sales by Country: 2021 VS 2025 VS 2032 (k pairs) Table 54. Global Knee-high Anti-Embolism Socks Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Knee-high Anti-Embolism Socks Sales by Country (2021-2026) & (k pairs) Table 56. Global Knee-high Anti-Embolism Socks Sales Market Share by Country (2021-2026) Table 57. Global Knee-high Anti-Embolism Socks Sales by Country (2027-2032) & (k pairs) Table 58. Global Knee-high Anti-Embolism Socks Sales Market Share by Country (2027-2032) Table 59. Global Knee-high Anti-Embolism Socks Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Knee-high Anti-Embolism Socks Sales Value Market Share by Country (2021-2026) Table 61. Global Knee-high Anti-Embolism Socks Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Knee-high Anti-Embolism Socks Sales Value Market Share by Country (2027-2032) Table 63. Varitek Company Information Table 64. Varitek Business Overview Table 65. Varitek Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 66. Varitek Knee-high Anti-Embolism Socks Product Portfolio Table 67. Varitek Recent Development Table 68. Medtronic(Covidien) Company Information Table 69. Medtronic(Covidien) Business Overview Table 70. Medtronic(Covidien) Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 71. Medtronic(Covidien) Knee-high Anti-Embolism Socks Product Portfolio Table 72. Medtronic(Covidien) Recent Development Table 73. Sigvaris Company Information Table 74. Sigvaris Business Overview Table 75. Sigvaris Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 76. Sigvaris Knee-high Anti-Embolism Socks Product Portfolio Table 77. Sigvaris Recent Development Table 78. Medi Company Information Table 79. Medi Business Overview Table 80. Medi Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 81. Medi Knee-high Anti-Embolism Socks Product Portfolio Table 82. Medi Recent Development Table 83. BSN Medical Company Information Table 84. BSN Medical Business Overview Table 85. BSN Medical Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 86. BSN Medical Knee-high Anti-Embolism Socks Product Portfolio Table 87. BSN Medical Recent Development Table 88. Juzo Company Information Table 89. Juzo Business Overview Table 90. Juzo Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 91. Juzo Knee-high Anti-Embolism Socks Product Portfolio Table 92. Juzo Recent Development Table 93. 3M Company Information Table 94. 3M Business Overview Table 95. 3M Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 96. 3M Knee-high Anti-Embolism Socks Product Portfolio Table 97. 3M Recent Development Table 98. Bauerfeind AG Company Information Table 99. Bauerfeind AG Business Overview Table 100. Bauerfeind AG Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 101. Bauerfeind AG Knee-high Anti-Embolism Socks Product Portfolio Table 102. Bauerfeind AG Recent Development Table 103. Thuasne Corporate Company Information Table 104. Thuasne Corporate Business Overview Table 105. Thuasne Corporate Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 106. Thuasne Corporate Knee-high Anti-Embolism Socks Product Portfolio Table 107. Thuasne Corporate Recent Development Table 108. Pretty Legs Hosiery Company Information Table 109. Pretty Legs Hosiery Business Overview Table 110. Pretty Legs Hosiery Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 111. Pretty Legs Hosiery Knee-high Anti-Embolism Socks Product Portfolio Table 112. Pretty Legs Hosiery Recent Development Table 113. Salzmann-Group Company Information Table 114. Salzmann-Group Business Overview Table 115. Salzmann-Group Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 116. Salzmann-Group Knee-high Anti-Embolism Socks Product Portfolio Table 117. Salzmann-Group Recent Development Table 118. Paul Hartmann Company Information Table 119. Paul Hartmann Business Overview Table 120. Paul Hartmann Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 121. Paul Hartmann Knee-high Anti-Embolism Socks Product Portfolio Table 122. Paul Hartmann Recent Development Table 123. Cizeta Medicali Company Information Table 124. Cizeta Medicali Business Overview Table 125. Cizeta Medicali Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 126. Cizeta Medicali Knee-high Anti-Embolism Socks Product Portfolio Table 127. Cizeta Medicali Recent Development Table 128. Belsana Medical Company Information Table 129. Belsana Medical Business Overview Table 130. Belsana Medical Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 131. Belsana Medical Knee-high Anti-Embolism Socks Product Portfolio Table 132. Belsana Medical Recent Development Table 133. Gloria Med Company Information Table 134. Gloria Med Business Overview Table 135. Gloria Med Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 136. Gloria Med Knee-high Anti-Embolism Socks Product Portfolio Table 137. Gloria Med Recent Development Table 138. Zhende Medical Group Company Information Table 139. Zhende Medical Group Business Overview Table 140. Zhende Medical Group Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 141. Zhende Medical Group Knee-high Anti-Embolism Socks Product Portfolio Table 142. Zhende Medical Group Recent Development Table 143. Maizi Company Information Table 144. Maizi Business Overview Table 145. Maizi Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 146. Maizi Knee-high Anti-Embolism Socks Product Portfolio Table 147. Maizi Recent Development Table 148. TOKO Company Information Table 149. TOKO Business Overview Table 150. TOKO Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 151. TOKO Knee-high Anti-Embolism Socks Product Portfolio Table 152. TOKO Recent Development Table 153. Okamoto Corporation Company Information Table 154. Okamoto Corporation Business Overview Table 155. Okamoto Corporation Knee-high Anti-Embolism Socks Sales (k pairs), Value (US$ Million), Price (USD/pair) and Gross Margin (2021-2026) Table 156. Okamoto Corporation Knee-high Anti-Embolism Socks Product Portfolio Table 157. Okamoto Corporation Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Knee-high Anti-Embolism Socks Distributors List Table 161. Knee-high Anti-Embolism Socks Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Knee-high Anti-Embolism Socks Product Image Figure 2. Global Knee-high Anti-Embolism Socks Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 4. Global Knee-high Anti-Embolism Socks Sales (2021-2032) & (k pairs) Figure 5. Global Knee-high Anti-Embolism Socks Sales Average Price (USD/pair) & (2021-2032) Figure 6. Global Knee-high Anti-Embolism Socks Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Open Toes Image Figure 10. Closed Toes Image Figure 11. Global Knee-high Anti-Embolism Socks Sales Volume by Type (2021 VS 2025 VS 2032) & (k pairs) Figure 12. Global Knee-high Anti-Embolism Socks Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Knee-high Anti-Embolism Socks Sales Volume Share by Type (2021-2032) Figure 14. Global Knee-high Anti-Embolism Socks Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Knee-high Anti-Embolism Socks Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Knee-high Anti-Embolism Socks Sales Value Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Knee-high Anti-Embolism Socks Sales Volume by Application (2021 VS 2025 VS 2032) & (k pairs) Figure 20. Global Knee-high Anti-Embolism Socks Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Knee-high Anti-Embolism Socks Sales Volume Share by Application (2021-2032) Figure 22. Global Knee-high Anti-Embolism Socks Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Knee-high Anti-Embolism Socks Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Knee-high Anti-Embolism Socks Sales Value Share by Application (2021-2032) Figure 25. Global Knee-high Anti-Embolism Socks Sales by Region: 2021 VS 2025 VS 2032 (k pairs) Figure 26. Global Knee-high Anti-Embolism Socks Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Knee-high Anti-Embolism Socks Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Knee-high Anti-Embolism Socks Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 30. North America Knee-high Anti-Embolism Socks Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Knee-high Anti-Embolism Socks Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Knee-high Anti-Embolism Socks Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 36. South America Knee-high Anti-Embolism Socks Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Knee-high Anti-Embolism Socks Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Knee-high Anti-Embolism Socks Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Knee-high Anti-Embolism Socks Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Knee-high Anti-Embolism Socks Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Open Toes
  • Closed Toes
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Varitek
  • Medtronic(Covidien)
  • Sigvaris
  • Medi
  • BSN Medical
  • Juzo
  • 3M
  • Bauerfeind AG
  • Thuasne Corporate
  • Pretty Legs Hosiery
  • Salzmann-Group
  • Paul Hartmann
  • Cizeta Medicali
  • Belsana Medical
  • Gloria Med
  • Zhende Medical Group
  • Maizi
  • TOKO
  • Okamoto Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  4. 1.2.2 Global Knee-high Anti-Embolism Socks Sales Volume (2021-2032)
  5. 1.2.3 Global Knee-high Anti-Embolism Socks Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Knee-high Anti-Embolism Socks Market Dynamics
  1. 2.1 Knee-high Anti-Embolism Socks Industry Trends
  2. 2.2 Knee-high Anti-Embolism Socks Industry Drivers
  3. 2.3 Knee-high Anti-Embolism Socks Industry Opportunities and Challenges
  4. 2.4 Knee-high Anti-Embolism Socks Industry Restraints
3 Knee-high Anti-Embolism Socks Market by Company
  1. 3.1 Global Knee-high Anti-Embolism Socks Company Revenue Ranking in 2025
  2. 3.2 Global Knee-high Anti-Embolism Socks Revenue by Company (2021-2026)
  3. 3.3 Global Knee-high Anti-Embolism Socks Sales Volume by Company (2021-2026)
  4. 3.4 Global Knee-high Anti-Embolism Socks Average Price by Company (2021-2026)
  5. 3.5 Global Knee-high Anti-Embolism Socks Company Ranking (2024-2026)
  6. 3.6 Global Knee-high Anti-Embolism Socks Company Manufacturing Base and Headquarters
  7. 3.7 Global Knee-high Anti-Embolism Socks Company Product Type and Application
  8. 3.8 Global Knee-high Anti-Embolism Socks Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Knee-high Anti-Embolism Socks Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Knee-high Anti-Embolism Socks Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Knee-high Anti-Embolism Socks Market by Type
  1. 4.1 Knee-high Anti-Embolism Socks Type Introduction
  2. 4.1.1 Open Toes
  3. 4.1.2 Closed Toes
  4. 4.2 Global Knee-high Anti-Embolism Socks Sales Volume by Type
  5. 4.2.1 Global Knee-high Anti-Embolism Socks Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Knee-high Anti-Embolism Socks Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Knee-high Anti-Embolism Socks Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Knee-high Anti-Embolism Socks Sales Value by Type
  9. 4.3.1 Global Knee-high Anti-Embolism Socks Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Knee-high Anti-Embolism Socks Sales Value by Type (2021-2032)
  11. 4.3.3 Global Knee-high Anti-Embolism Socks Sales Value Share by Type (2021-2032)
5 Knee-high Anti-Embolism Socks Market by Application
  1. 5.1 Knee-high Anti-Embolism Socks Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Knee-high Anti-Embolism Socks Sales Volume by Application
  5. 5.2.1 Global Knee-high Anti-Embolism Socks Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Knee-high Anti-Embolism Socks Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Knee-high Anti-Embolism Socks Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Knee-high Anti-Embolism Socks Sales Value by Application
  9. 5.3.1 Global Knee-high Anti-Embolism Socks Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Knee-high Anti-Embolism Socks Sales Value by Application (2021-2032)
  11. 5.3.3 Global Knee-high Anti-Embolism Socks Sales Value Share by Application (2021-2032)
6 Knee-high Anti-Embolism Socks Regional Sales and Value Analysis
  1. 6.1 Global Knee-high Anti-Embolism Socks Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Knee-high Anti-Embolism Socks Sales by Region (2021-2032)
  3. 6.2.1 Global Knee-high Anti-Embolism Socks Sales by Region: 2021-2026
  4. 6.2.2 Global Knee-high Anti-Embolism Socks Sales by Region (2027-2032)
  5. 6.3 Global Knee-high Anti-Embolism Socks Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Knee-high Anti-Embolism Socks Sales Value by Region (2021-2032)
  7. 6.4.1 Global Knee-high Anti-Embolism Socks Sales Value by Region: 2021-2026
  8. 6.4.2 Global Knee-high Anti-Embolism Socks Sales Value by Region (2027-2032)
  9. 6.5 Global Knee-high Anti-Embolism Socks Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  12. 6.6.2 North America Knee-high Anti-Embolism Socks Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  15. 6.7.2 Europe Knee-high Anti-Embolism Socks Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Knee-high Anti-Embolism Socks Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  21. 6.9.2 South America Knee-high Anti-Embolism Socks Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Knee-high Anti-Embolism Socks Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Knee-high Anti-Embolism Socks Sales Value Share by Country, 2025 VS 2032
7 Knee-high Anti-Embolism Socks Country-level Sales and Value Analysis
  1. 7.1 Global Knee-high Anti-Embolism Socks Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Knee-high Anti-Embolism Socks Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Knee-high Anti-Embolism Socks Sales by Country (2021-2032)
  4. 7.3.1 Global Knee-high Anti-Embolism Socks Sales by Country (2021-2026)
  5. 7.3.2 Global Knee-high Anti-Embolism Socks Sales by Country (2027-2032)
  6. 7.4 Global Knee-high Anti-Embolism Socks Sales Value by Country (2021-2032)
  7. 7.4.1 Global Knee-high Anti-Embolism Socks Sales Value by Country (2021-2026)
  8. 7.4.2 Global Knee-high Anti-Embolism Socks Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Knee-high Anti-Embolism Socks Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Knee-high Anti-Embolism Socks Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Knee-high Anti-Embolism Socks Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Varitek
  2. 8.1.1 Varitek Company Information
  3. 8.1.2 Varitek Business Overview
  4. 8.1.3 Varitek Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Varitek Knee-high Anti-Embolism Socks Product Portfolio
  6. 8.1.5 Varitek Recent Developments
  7. 8.2 Medtronic(Covidien)
  8. 8.2.1 Medtronic(Covidien) Company Information
  9. 8.2.2 Medtronic(Covidien) Business Overview
  10. 8.2.3 Medtronic(Covidien) Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic(Covidien) Knee-high Anti-Embolism Socks Product Portfolio
  12. 8.2.5 Medtronic(Covidien) Recent Developments
  13. 8.3 Sigvaris
  14. 8.3.1 Sigvaris Company Information
  15. 8.3.2 Sigvaris Business Overview
  16. 8.3.3 Sigvaris Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sigvaris Knee-high Anti-Embolism Socks Product Portfolio
  18. 8.3.5 Sigvaris Recent Developments
  19. 8.4 Medi
  20. 8.4.1 Medi Company Information
  21. 8.4.2 Medi Business Overview
  22. 8.4.3 Medi Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Medi Knee-high Anti-Embolism Socks Product Portfolio
  24. 8.4.5 Medi Recent Developments
  25. 8.5 BSN Medical
  26. 8.5.1 BSN Medical Company Information
  27. 8.5.2 BSN Medical Business Overview
  28. 8.5.3 BSN Medical Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BSN Medical Knee-high Anti-Embolism Socks Product Portfolio
  30. 8.5.5 BSN Medical Recent Developments
  31. 8.6 Juzo
  32. 8.6.1 Juzo Company Information
  33. 8.6.2 Juzo Business Overview
  34. 8.6.3 Juzo Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Juzo Knee-high Anti-Embolism Socks Product Portfolio
  36. 8.6.5 Juzo Recent Developments
  37. 8.7 3M
  38. 8.7.1 3M Company Information
  39. 8.7.2 3M Business Overview
  40. 8.7.3 3M Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 3M Knee-high Anti-Embolism Socks Product Portfolio
  42. 8.7.5 3M Recent Developments
  43. 8.8 Bauerfeind AG
  44. 8.8.1 Bauerfeind AG Company Information
  45. 8.8.2 Bauerfeind AG Business Overview
  46. 8.8.3 Bauerfeind AG Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bauerfeind AG Knee-high Anti-Embolism Socks Product Portfolio
  48. 8.8.5 Bauerfeind AG Recent Developments
  49. 8.9 Thuasne Corporate
  50. 8.9.1 Thuasne Corporate Company Information
  51. 8.9.2 Thuasne Corporate Business Overview
  52. 8.9.3 Thuasne Corporate Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thuasne Corporate Knee-high Anti-Embolism Socks Product Portfolio
  54. 8.9.5 Thuasne Corporate Recent Developments
  55. 8.10 Pretty Legs Hosiery
  56. 8.10.1 Pretty Legs Hosiery Company Information
  57. 8.10.2 Pretty Legs Hosiery Business Overview
  58. 8.10.3 Pretty Legs Hosiery Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pretty Legs Hosiery Knee-high Anti-Embolism Socks Product Portfolio
  60. 8.10.5 Pretty Legs Hosiery Recent Developments
  61. 8.11 Salzmann-Group
  62. 8.11.1 Salzmann-Group Company Information
  63. 8.11.2 Salzmann-Group Business Overview
  64. 8.11.3 Salzmann-Group Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Salzmann-Group Knee-high Anti-Embolism Socks Product Portfolio
  66. 8.11.5 Salzmann-Group Recent Developments
  67. 8.12 Paul Hartmann
  68. 8.12.1 Paul Hartmann Company Information
  69. 8.12.2 Paul Hartmann Business Overview
  70. 8.12.3 Paul Hartmann Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Paul Hartmann Knee-high Anti-Embolism Socks Product Portfolio
  72. 8.12.5 Paul Hartmann Recent Developments
  73. 8.13 Cizeta Medicali
  74. 8.13.1 Cizeta Medicali Company Information
  75. 8.13.2 Cizeta Medicali Business Overview
  76. 8.13.3 Cizeta Medicali Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cizeta Medicali Knee-high Anti-Embolism Socks Product Portfolio
  78. 8.13.5 Cizeta Medicali Recent Developments
  79. 8.14 Belsana Medical
  80. 8.14.1 Belsana Medical Company Information
  81. 8.14.2 Belsana Medical Business Overview
  82. 8.14.3 Belsana Medical Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Belsana Medical Knee-high Anti-Embolism Socks Product Portfolio
  84. 8.14.5 Belsana Medical Recent Developments
  85. 8.15 Gloria Med
  86. 8.15.1 Gloria Med Company Information
  87. 8.15.2 Gloria Med Business Overview
  88. 8.15.3 Gloria Med Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Gloria Med Knee-high Anti-Embolism Socks Product Portfolio
  90. 8.15.5 Gloria Med Recent Developments
  91. 8.16 Zhende Medical Group
  92. 8.16.1 Zhende Medical Group Company Information
  93. 8.16.2 Zhende Medical Group Business Overview
  94. 8.16.3 Zhende Medical Group Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Zhende Medical Group Knee-high Anti-Embolism Socks Product Portfolio
  96. 8.16.5 Zhende Medical Group Recent Developments
  97. 8.17 Maizi
  98. 8.17.1 Maizi Company Information
  99. 8.17.2 Maizi Business Overview
  100. 8.17.3 Maizi Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Maizi Knee-high Anti-Embolism Socks Product Portfolio
  102. 8.17.5 Maizi Recent Developments
  103. 8.18 TOKO
  104. 8.18.1 TOKO Company Information
  105. 8.18.2 TOKO Business Overview
  106. 8.18.3 TOKO Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 TOKO Knee-high Anti-Embolism Socks Product Portfolio
  108. 8.18.5 TOKO Recent Developments
  109. 8.19 Okamoto Corporation
  110. 8.19.1 Okamoto Corporation Company Information
  111. 8.19.2 Okamoto Corporation Business Overview
  112. 8.19.3 Okamoto Corporation Knee-high Anti-Embolism Socks Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Okamoto Corporation Knee-high Anti-Embolism Socks Product Portfolio
  114. 8.19.5 Okamoto Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Knee-high Anti-Embolism Socks Value Chain Analysis
  2. 9.1.1 Knee-high Anti-Embolism Socks Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Knee-high Anti-Embolism Socks Sales Mode & Process
  6. 9.2 Knee-high Anti-Embolism Socks Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Knee-high Anti-Embolism Socks Distributors
  9. 9.2.3 Knee-high Anti-Embolism Socks Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst